Hu L, Fan C, Bross P, Das A, et al. FDA approval summary: Lifileucel for unresectable or metastatic melanoma previously treated with an anti-PD-1 based immunotherapy. Clin Cancer Res 2025 Jul 23. doi: 10.1158/1078-0432.CCR-25-0880.
PMID: 40699950